Telesis Bio, Inc. / Fundamentals

    Income statement

    Net revenue
    €11.66M
    Cost of goods sold
    €7.72M
    Gross profit
    €3.94M
    SG&A expenses
    €20.87M
    R&D expenses
    €9.12M
    EBITDA
    -€23.70M
    D&A
    €3.10M
    EBIT
    -€26.33M
    Interest expenses
    €1.96M
    EBT
    -€37.96M
    Tax expenses
    €6.03K
    Net income
    -€39.24M

    Cash flow statement

    Net deferred tax
    -€5.34M
    Non-cash items
    €18.92M
    Changes in working capital
    €502.28K
    Operating cash flow
    -€19.69M
    Capex
    €766.78K
    Other investing cash flow
    €20.67M
    Net investing cash flow
    €20.95M
    Total cash dividends paid
    €0.00
    Issuance of common stock
    €22.91M
    Debt repayment
    -€17.33M
    Other financing cash flow
    €4.21M
    Net financing cash flow
    -€13.12M
    Foreign exchange effects
    €9.48K
    Net change in cash
    -€6.25M
    Cash at end of period
    €3.29M
    Free cash flow
    -€18.92M

    Balance sheet

    Cash and cash equivalents
    €3.20M
    Cash and short-term investments
    €3.89M
    Total receivables
    €1.09M
    Inventory
    €946.84K
    Other current assets
    €1.07M
    Total current assets
    €7.00M
    Property, plant & equipment
    €10.33M
    Goodwill
    €3.01M
    Intangible assets
    €549.67K
    Long-term investments
    €0.00
    Other non-current assets
    €423.02K
    Total non-current assets
    €14.32M
    Total assets
    €21.31M
    Accounts payable
    €1.29M
    Short-term debt
    €1.90M
    Other current liabilities
    €2.52M
    Total current liabilities
    €5.71M
    Long-term debt
    €12.14M
    Deferred tax liabilities
    €0.00
    Other non-current liabilities
    €128.37K
    Total non-current liabilities
    €12.26M
    Total liabilities
    €17.97M
    Common stock
    €0.00
    Retained earnings
    -€163.12M
    Other equity
    -€4.31K
    Total equity
    €3.34M
    Total liabilities and shareholders' equity
    €21.31M

    Company information

    Market capitalization
    €822.45K
    Employees
    39
    Enterprise Value
    €12.67M

    Company ratios

    Gross margin
    33.8%
    EBITDA margin
    -203.3%
    EBIT margin
    -225.8%
    EBT margin
    -325.6%
    Net margin
    -336.6%
    ROE
    -1,175.8%
    ROA
    -184.1%
    Asset turnover
    54.7%
    FCF margin
    -175.5%
    FCF yield
    -2,487.3%
    Efficiency ratio
    303.3%
    Net sales per employee
    €298.96K
    Net income per employee
    -€1.01M

    Notifications